课题基金 / 基金详情

Advancing Melanoma Treatment through Novel Immunomodulating Photosensitizing Agents

Advancing Melanoma Treatment through Novel Immunomodulating Photosensitizing Agents
通过新型免疫调节光敏剂推进黑色素瘤治疗
批准号：
333022
负责人：
Mcfarland Sherri A
金额：
$7.29万
依托单位：
Acadia University (Nova Scotia)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-05-01 至 2016-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=333022&lang=en
关键词：
Cancer Therapeutics Cell / Tissue Culture Coordination Chemistry Immunomodulating Agents Laser Spectroscopy / Confocal Microscopy Melanoma Photodynamic Therapy (Pdt) / Photochemotherapy (Pact) Photophysics / Photochemistry / Photobiology Photosens

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
黑色素瘤是黑色素细胞的癌症，黑色素细胞是位于皮肤和全身的黑色素产生细胞。黑色素是一种复杂的色素，通过清除活性中间体来保护身体免受阳光伤害和环境毒素的伤害。翁福通
英文摘要
Melanoma is a cancer of melanocytes, which are melanin-producing cells located in the skin and throughout the body. Melanin is a complex pigment that protects the body from sun damage and environmental toxins by scavenging reactive intermediates. Unfortun
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金